The Abramson Cancer Center has an extensive and well-established internal, institutional and external? planning and evaluation process. Planning is accomplished at many levels and includes several formal? internal and external bodies, such as the Senior Leadership Council, Executive Committee, Program? Leaders, Shared Resource Advisory Committees, institutional planning groups, external consultants, and,? most importantly, the External Board of Scientific Advisors. Program and divisional retreats and meetings? provide additional forums for the review of strategic goals and accomplishments by Cancer Center members? as well as external reviewers.? During the current period, the most significant change in planning and evaluation has been that the Cancer? Center's primary external advisory group, the External Board of Scientific Advisors, has been strengthened? significantly and is fully integrated into the Cancer Center's planning efforts. The recruitment of new? members has resulted in a highly effective External Board, which reflects the research priorities of the? Cancer Center. Chaired by Frederick Appelbaum, MD, the External Board meets annually to review the? Cancer Center's scientific research directions, interdisciplinary research opportunities, future plans, and? Shared Resources. The External Board helps ensure that the Cancer Center continues to strive for? excellence and adheres to NCI Guidelines. The Cancer Center actively responds to External Board? recommendations after each meeting, and then reports on its actions at the next meeting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-32
Application #
7726707
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
32
Fiscal Year
2007
Total Cost
$25,458
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Torre, Eduardo; Dueck, Hannah; Shaffer, Sydney et al. (2018) Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH. Cell Syst 6:171-179.e5
Echevarría-Vargas, Ileabett M; Reyes-Uribe, Patricia I; Guterres, Adam N et al. (2018) Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma. EMBO Mol Med 10:
Romero, Sally A D; Jones, Lee; Bauml, Joshua M et al. (2018) The association between fatigue and pain symptoms and decreased physical activity after cancer. Support Care Cancer 26:3423-3430
Vonderheide, Robert H (2018) The Immune Revolution: A Case for Priming, Not Checkpoint. Cancer Cell 33:563-569
Kall, Stefanie L; Delikatny, Edward J; Lavie, Arnon (2018) Identification of a Unique Inhibitor-Binding Site on Choline Kinase ?. Biochemistry 57:1316-1325
Safo, Sandra E; Li, Shuzhao; Long, Qi (2018) Integrative analysis of transcriptomic and metabolomic data via sparse canonical correlation analysis with incorporation of biological information. Biometrics 74:300-312
Quast, Lauren F; Phillips, Peter C; Li, Yimei et al. (2018) A prospective study of family predictors of health-related quality of life in pediatric brain tumor survivors. Pediatr Blood Cancer 65:e26976
Bart, Stephen M; Cohen, Courtney; Dye, John M et al. (2018) Enhancement of Ebola virus infection by seminal amyloid fibrils. Proc Natl Acad Sci U S A 115:7410-7415
Ecker, Christopher; Guo, Lili; Voicu, Stefana et al. (2018) Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments. Cell Rep 23:741-755
Alexander, Erica S; Mick, Rosemarie; Nadolski, Gregory J et al. (2018) Combined chemoembolization and thermal ablation for the treatment of metastases to the liver. Abdom Radiol (NY) 43:2859-2867

Showing the most recent 10 out of 1047 publications